Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $106,725 - $140,157
1,107 Added 43.93%
3,627 $374,000
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $106,531 - $144,316
-899 Reduced 26.29%
2,520 $306,000
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $183,412 - $266,371
1,352 Added 65.41%
3,419 $525,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $244,691 - $434,152
2,067 New
2,067 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capital Group Investment Management Pte. Ltd. Portfolio

Follow Capital Group Investment Management Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.